These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 11120977)

  • 1. Clinical isolation and resistance patterns of and superinfection with 10 nosocomial pathogens after treatment with ceftriaxone versus ampicillin-sulbactam.
    Carmeli Y; Castro J; Eliopoulos GM; Samore MH
    Antimicrob Agents Chemother; 2001 Jan; 45(1):275-9. PubMed ID: 11120977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind comparison of ampicillin/sulbactam and ceftriaxone in the prevention of surgical-site infections after neurosurgery.
    Zhu XL; Wong WK; Yeung WM; Mo P; Tsang CS; Pang KH; Po YC; Aung TH
    Clin Ther; 2001 Aug; 23(8):1281-91. PubMed ID: 11558864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for recovery of ampicillin-sulbactam-resistant Escherichia coli in hospitalized patients.
    Kaye KS; Harris AD; Gold H; Carmeli Y
    Antimicrob Agents Chemother; 2000 Apr; 44(4):1004-9. PubMed ID: 10722504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests].
    Vitkauskiene A; Sakalauskas R; Dudzevicius V
    Medicina (Kaunas); 2003; 39(3):254-9. PubMed ID: 12695638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal septicaemia in Ilorin: bacterial pathogens and antibiotic sensitivity pattern.
    Mokuolu AO; Jiya N; Adesiyun OO
    Afr J Med Med Sci; 2002 Jun; 31(2):127-30. PubMed ID: 12518907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized comparative study of ampicillin/sulbactam vs. ceftriaxone for treatment of soft tissue and skeletal infections in children.
    Kulhanjian J; Dunphy MG; Hamstra S; Levernier K; Rankin M; Petru A; Azimi P
    Pediatr Infect Dis J; 1989 Sep; 8(9):605-10. PubMed ID: 2677956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli.
    Harbarth S; Harris AD; Carmeli Y; Samore MH
    Clin Infect Dis; 2001 Nov; 33(9):1462-8. PubMed ID: 11588690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Successful treatment of a patient with multidrug resistant Acinetobacter baumannii meningitis with high dose ampicillin-sulbactam].
    Sayin Kutlu S; Saçar S; Süzer T; Cevahir N; Okke D; Dirgen Caylak S; Turgut H
    Mikrobiyol Bul; 2008 Apr; 42(2):353-8. PubMed ID: 18697435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of ampicillin-sulbactam for empiric treatment of ventilator-associated pneumonia in a trauma population.
    McMillian WD; Bednarik JL; Aloi JJ; Ahern JW; Crookes BA
    J Trauma; 2010 Oct; 69(4):861-5. PubMed ID: 20938272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose ampicillin/sulbactam versus ceftriaxone as treatment for uncomplicated gonorrhoea in a Ugandan STD clinic population with a high prevalence of PPNG infection.
    Hellmann NS; Nsubuga PS; Baingana-Baingi DJ; Desmond-Hellmann SD; Mbidde EK; Granowitz CB; Sande MA
    J Trop Med Hyg; 1995 Apr; 98(2):95-100. PubMed ID: 7714943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistance of pathogens causing nosocomial infection in orthopedics from 2012 to 2017: a 6-year retrospective study.
    Yang X; Guo R; Xie B; Lai Q; Xu J; Hu N; Wan L; Dai M; Zhang B
    J Orthop Surg Res; 2021 Feb; 16(1):100. PubMed ID: 33522930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic/adjuvant combinations (ceftriaxone + sulbactam + adjuvant disodium edetate) as an alternative empiric therapy for the treatment of nosocomial infections: Results of a retrospective study.
    Chakravorty S; Arun P
    Indian J Cancer; 2017; 54(4):685-690. PubMed ID: 30082559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of treatment with single-dose ampicillin/sulbactam with probenecid or ceftriaxone in patients with uncomplicated gonorrhea.
    Baddour LM; Busby L; Shapiro E; Cox KB; Glassco S; Johnson JK
    Sex Transm Dis; 1992; 19(6):341-5. PubMed ID: 1492262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical experience with the treatment of severe nosocomial infections by inhibitor-protected 3rd generation cephalosporin cefoperazone/sulbactam].
    Beloborodova NV; Kuznetsova ST; Popov DA; Bachinskaia EN; Vostrikov TIu
    Antibiot Khimioter; 2005; 50(4):33-40. PubMed ID: 16392338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.
    Gavaldá J; Onrubia PL; Gómez MT; Gomis X; Ramírez JL; Len O; Rodríguez D; Crespo M; Ruíz I; Pahissa A
    J Antimicrob Chemother; 2003 Sep; 52(3):514-7. PubMed ID: 12917251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative antibiotic use in high-risk penetrating hollow viscus injury: a prospective randomized, double-blind, placebo-control trial of 24 hours versus 5 days.
    Kirton OC; O'Neill PA; Kestner M; Tortella BJ
    J Trauma; 2000 Nov; 49(5):822-32. PubMed ID: 11086771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
    Chen MJ; Wang H;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with ceftriaxone treatment in the neonate.
    Van Reempts PJ; Van Overmeire B; Mahieu LM; Vanacker KJ
    Chemotherapy; 1995; 41(4):316-22. PubMed ID: 7555213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections.
    Falagas ME; Barefoot L; Griffith J; Ruthazar R; Snydman DR
    Eur J Clin Microbiol Infect Dis; 1996 Dec; 15(12):913-21. PubMed ID: 9031873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.